Brief: Genmab Reports H1 Operating Profit Of $555 Million
BRIEF-Genmab Reports H1 Operating Profit Of $555 Million Aug 6 (Reuters) - Genmab A/S GMAB.CO:
GENMAB H1 OPERATING PROFIT USD 555 MILLION
GENMAB - H1 REVENUE INCREASES 25% TO $2.05 BILLION
GENMAB - EXPECTS FULL YEAR REVENUE AT $4,325 - 4,525 MILLION
GENMAB - SEES 2026 ADJUSTED OPERATING PROFIT IN RANGE OF $1,065 - $1,385 MILLION
Source text: ID:nGNE3knt6N
Further company coverage: GMAB.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos